Evidence map›Paper›PMID 34865350›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2020

[Application of serum N -glycan profiling diagnostic model in evaluation of liver fibrosis in patients with hepatitis C].

X Cao, Y Zhang, Y M Nan, Z N Tan, C Y Chen, Q H Shang, X E Liu, H Zhuang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

X CaoDepartment of Microbiology and Center of Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Y ZhangDepartment of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Hebei, Shijiazhuang 050000, China.
Y M NanDepartment of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Hebei, Shijiazhuang 050000, China.
Z N TanDepartment of Molecular Biomedical Research, Xian si-da Biotechnology Company Limited, Nanjing 210000, China.
C Y ChenDepartment of Molecular Biomedical Research, Xian si-da Biotechnology Company Limited, Nanjing 210000, China.
Q H ShangDepartment of Liver Disease, No. 88 Hospital of Chinese People's Liberation Army, Tai'an 271000, China.
X E LiuDepartment of Microbiology and Center of Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
H ZhuangDepartment of Microbiology and Center of Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.

Funding

Major Science and Technology Special Project of China Thirteenth Five-year Plan 2018ZX10732401-003-015Project of the Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis GXCDCKL201901
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HepacivirusHepatitis CAspartate AminotransferasesHumansLiver CirrhosisPolysaccharidesAspartate AminotransferasesPolysaccharidesDiagnostic modelsHepatitis C, chronicLiver cirrhosisN-glycome

Identifiers

PMID34865350
PMCPMC12770255

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.